Drug Topics E-News:
Having trouble viewing this e-mail? Click here. 		You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
Modern Medicine Network
Resource Centers
CME/CE
Medical Economics
Careers
Community
Clinical Tools
  Drug Topics E-News
 
December 15, 2009
IN THIS ISSUE
• 2010 business outlook
• Review: New drugs 2009
• Transplant drug leads
• HITECH beefs up HIPAA
  TOP SEARCHES: medicare // CE // diabetes

Drug Topics' 2010 business outlook survey
Respondents to this year's business outlook survey are generally upbeat about the business their pharmacies are doing and their prospects for the coming year. More....

Focus on 2009: A year of novel pharmacologic agents in review
Recent FDA action (through December 2009) related to denosumab, binodenoson, toremifene 80 mg, zolpidem tartrate sublingual tablet, QAB149, raxibacumab, rituximab, pneumococcal 13-valent conjugate vaccine, velaglucerase alfa, sirolimus ophthalmic injection, custirsen, GSK-3 inhibitor, aztreonam for inhalation solution, rosuvastatin calcium tablets More...

Transplant induction agent leads in clinical trial
Wake Forest University Baptist Medical Center has announced results of a clinical trial comparing alemtuzumab and antithymocyte globulin, agents used in induction before renal and pancreatic transplants. More...

HITECH Act calls for new HIPAA notice requirements
The American Recovery and Reinvestment Act, signed into law on February 17, included the Health Information Technology for Economic and Clinical Health Act (HITECH), which expands covered-entity and business-associate requirements established by the Health Insurance Portability and Accountability Act of 1996 (HIPAA). More...


Key Topic Updates
Issues & Trends
 
Professional
 
Clinical
 
Technology
 
Regulatory & Legal

Key Topic Updates

Survey

Is knowledge of herbal supplements valuable to you in the practice of pharmacy?
No, not at all.
 
8%
Yes, somewhat.   27%
Definitely helpful.   43%
It comes up daily.   22%

This month we would like to know...

How many of your patients fill three or more standing prescriptions every month?

1%-15%
15%-30%
30%-50%
More than 50%

Click here to vote

Contact Us
Click here to learn more about the Drug Topics editorial team.

Click here to contact the Drug Topics editorial team.

Click here to contact the Drug Topics sales team.

Click here to learn about direct mail, reprints and classifieds in Drug Topics.

Drug Topics Digital Edition
Click here to to view the most recent issue.

Click here to subscribe.

Follow us on Twitter.

Share Drug Topics E-News with a friend

You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.